CONMED Corp. 10-Q Summary: Quarter Ended June 30, 1995
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 1995, and the six-month period ended June 30, 1995, for CONMED Corporation. The company is engaged in the development, manufacturing, and marketing of disposable medical products and related devices. The reporting period is characterized by significant growth driven by two major acquisitions: Birtcher Medical Systems (March 1995) and The Master Medical Corporation (May 1995).
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended 6/30/95 | 6 Months Ended 6/30/95 |
|---|---|---|
| Net Sales | $25,875 | $45,628 |
| Net Income | $2,818 | $4,658 |
| Earnings Per Share | $0.36 | $0.63 |
| Gross Margin | 47.8% | 46.9% |
| Operating Income | $4,928 | $7,954 |
| Cash from Operations | N/A | $512 |
| Total Debt (Current + Long-term) | N/A | $35,340 |
| Cash and Equivalents | N/A | $2,286 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 47.5% for the quarter and 28.9% for the six-month period compared to the prior year, primarily due to the inclusion of acquired businesses.
- Profitability: Net income rose 123% for the quarter and 93% for the six-month period. Gross margins improved to 47.8% (quarter) and 46.9% (six months) from 45.3% and 44.6% respectively, attributed to manufacturing efficiencies and economies of scale.
- Expense Management: While Selling and Administrative (S&A) expenses increased in absolute dollars due to acquisitions, they declined as a percentage of sales to 26.2% (quarter) and 26.6% (six months) from 30.0% and 30.2% in the prior year.
- Balance Sheet Expansion: Total assets nearly doubled from $62.1 million to $116.2 million, driven by a $33.9 million increase in Goodwill and a $10.0 million increase in Inventories. Total liabilities increased from $19.0 million to $49.9 million due to debt incurred for acquisitions.
- Cash Flow: Net cash provided by operations decreased significantly to $512,000 for the six months ended June 30, 1995, compared to $3.2 million in the prior year. This was due to increased working capital requirements (inventories and receivables) and the payment of a patent litigation award.
Outlook, Risks, and Unusual Items
- Acquisitions: The company acquired Birtcher Medical Systems for approximately $17.75 million in stock and $9.3 million in assumed liabilities, and Master Medical Corporation for $9.5 million in cash. Pro forma results suggest these acquisitions would have increased net income to $5.57 million for the six-month period.
- Debt and Liquidity: The company refinanced its debt, resulting in a $30 million term loan and a $10 million revolving credit line. As of June 30, 1995, $30 million was outstanding on the term loan and $5.34 million on the revolver. Management believes current resources and credit facilities are sufficient for future operations.
- Legal Matters: The company paid a $2.1 million patent infringement award (plus interest) in the quarter ended June 1995, following an appellate court affirmation. Adequate provision for this award was made in 1993.
- Capital Expenditures: The company purchased land and a building in Rome, New York, for $1.2 million to support manufacturing expansion.
Investor Verification Checklist
- Verify the integration progress and revenue contribution of the Birtcher and Master Medical acquisitions.
- Monitor the impact of increased debt levels ($35.3 million total) on future interest expenses and cash flow.
- Assess the sustainability of gross margin improvements as the company scales operations.
- Review the status of the Rome, New York manufacturing expansion and its timeline for operational readiness.
- Confirm that no further legal contingencies exist regarding the resolved patent litigation.